NPPA: Manufacturers of N-95 masks directed to maintain parity in prices for non-govt procurements to curb black marketing
Manufacturers, importers and suppliers of N-95 has been directed by the National Pharmaceutical Pricing Authority (NPPA) for maintaining parity in prices for non-government procurements for the purpose of making available…
DoP proposes to oversee drug regulator
As the government plans a major overhaul of the country’s drug authority, the Department of Pharmaceuticals (DoP) has proposed to oversee Central Drugs Standard Control Organisation (CDSCO) to be transferred…
Successful Kidney Transplant in an Old Man, 62, amidst COVID 19 Fears
New Delhi: Dr NK Gupta, 62 years of old, underwent a successful kidney transplant at Indraprastha Apollo Hospitals. A medical practitioner himself, Dr Gupta had been undergoing multiple sessions of…
International Online AYURVEDA Dialogue Tomorrow to defeat COVID
New Delhi: As Allopathy flounders in the face of COVID 19 and seems to be at its wit’s end, Ayurveda comes forward with its time tested Rasayanas, potions and natural…
COVID-19: DCGI approved NovaLead Pharma to conduct clinical
The Drugs Controller General of India (DCGI) has granted approval to NovaLead Pharma for conducting of phase III clinical trials for its repurposed drug discovery for treatemnt of moderate COVID-19…
CDSCO observed shortage of 15 drugs
A letter has been issued by the Central Drugs Standard Control Organisation (CDSCO) to all drug manufacturers associations giving an information about the low supply of 15 essential drugs which…
Director of Himachal Health Services arrested in ‘corruption case’
Dr Ajay Gupta, The Director of Himachal Pradesh Health Services, was arrested by the state Vigilance and Anti-Corruption Bureau allegedly in a corruption case on the basis of audio recording.…
Aster DM Healthcare to groom people for New Normal post COVID
Dubai/ New Delhi: Aster DM Healthcare – one of the largest private, integrated healthcare service providers across the GCC and an emerging player in India has launched ‘Our New Earth’,…
Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease approved by DCGI
May 20, 2020: Drugs Controller General of India (DCGI) has approved Nintedanib by Boehringer Ingelheim (India) in treating systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults. Earlier on 3rd March,…
59 product licenses to 37 new comapines to manufacture azithromycin approved by Gujarat FDCA
The Gujarat Food and Drug Control Administration (FDCA) has approved 59 product licenses to 37 manufacturers for production of azithromycin as a basic treatment for Covid-19 patients. Hydroxychloroquine (HCQ) in…
